Public Profile

Vectura

Vectura Group plc, headquartered in Great Britain, is a leading player in the pharmaceutical industry, specialising in the development of inhalation products and drug delivery solutions. Founded in 1997, Vectura has achieved significant milestones, including partnerships with major pharmaceutical companies to enhance respiratory therapies. The company focuses on innovative formulations and device technologies, particularly for asthma and chronic obstructive pulmonary disease (COPD). Vectura's unique approach combines expertise in inhalation science with advanced manufacturing capabilities, positioning it as a trusted partner in the respiratory market. With a strong presence in Europe and North America, Vectura has established itself as a key contributor to improving patient outcomes through its core products and services. Its commitment to research and development continues to drive its success and market leadership in the inhalation therapeutics sector.

DitchCarbon Score

How does Vectura's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Vectura's score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Vectura's reported carbon emissions

Vectura, headquartered in Great Britain, has reported significant carbon emissions over the years, with the most recent data available from 2019. In that year, Vectura's total emissions amounted to approximately 2,763,000 kg CO2e for Scope 1 and about 1,172,000 kg CO2e for Scope 2, resulting in a combined total of around 3,935,000 kg CO2e. In previous years, emissions have varied, with 2018 showing approximately 2,543,000 kg CO2e for Scope 1 and about 1,249,000 kg CO2e for Scope 2, leading to a total of around 3,792,000 kg CO2e. The year 2017 recorded the highest emissions, with about 2,312,000 kg CO2e for Scope 1 and approximately 1,522,000 kg CO2e for Scope 2, totalling around 3,834,000 kg CO2e. Despite these figures, Vectura has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or SBTi (Science Based Targets initiative) reduction targets suggests that while Vectura is aware of its emissions, it has yet to commit to formalised reduction strategies. Overall, Vectura's emissions data highlights the need for ongoing monitoring and potential action to align with industry standards for climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142016201720182019
Scope 1
142,000
000,000
0,000,000
0,000,000
0,000,000
Scope 2
1,272,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vectura's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vectura is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vectura is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aquestive Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Novartis Pharmaceuticals UK Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

RECORDATI

LU
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Cosmo Pharmaceuticals N.V.

IE
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Collegium Pharmaceutical, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Pharma Mar

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 18 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers